Morteza Ghasemnejad-Berenji

37PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Metabolic medicineSolid tumoursCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|Jan 31, 2026
The interplay between circadian rhythm components and apoptosis in health and disease.

Mohammad Rafi Khezri, Somayeh Mohammadi Panah, Morteza Ghasemnejad-Berenji

|Apr 15, 2025
The Protective Effects of Metformin and Vitamin C and Their Co-Administration in Bleomycin-Induced Pulmonary Fibrosis in Mice.

Mohammad Ebrahim Abbaszadeh, Mohammad Rafi Khezri, Morteza Ghasemnejad-Berenji

|Feb 04, 2025
Metformin alleviates doxorubicin-induced hepatic damage by modulating oxidative stress: a molecular, biochemical, and histopathological approach in a rat model.

Shabnam Lal-Shahsavar, Naime Majidi Zolbanin, Abbas Jafari

|Sep 03, 2024
Metformin and the PI3K/AKT signaling pathway: implications for cancer, cardiovascular, and central nervous system diseases.

Hemin Ashayeri Ahmadabad, Somayeh Mohammadi Panah, Hojat Ghasemnejad-Berenji

|Apr 21, 2024
Empagliflozin protective effects against cisplatin-induced acute nephrotoxicity by interfering with oxidative stress and inflammation in Wistar rats.

Nika Farrokh-Eslamlou, Saeideh Momtaz, Amirhossein Niknejad

Pageof 7